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MVC administration for 3 days blocked
ex vivo virus infection of LCs as well as
subsequent virus transmission when dif-
ferent R5 HIV strains, HIVAD8 and
HIVJR-FL, were utilized for an additional
six subjects (n¼3 for each strain,
Figures 1 and 2). These data demon-
strate that oral administration of MVC
for at least 3 days is capable of fully
protecting HIV infection of LCs within
epithelial tissue.
These experiments provide perhaps
the best proof-of-concept test for MVC
as a potential PrEP drug, as it would
be unethical to expose MVC-treated
volunteers to HIV in vivo. As proven
here, orally delivered MVC rapidly distri-
butes to skin and functionally acts to block
infection of relevant target cells, LCs,
supporting randomized controlled trials
of MVC as a PrEP therapy for individuals
at high risk of becoming infected with HIV
through sexual exposure.
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TO THE EDITOR
Punctate palmoplantar keratoderma
(punctate PPK or PPKP) is a rare
autosomal dominant disorder of kera-
tinization. Three variants of this disease
have been described; PPKP1 (OMIM
x148600, Buschke–Fischer–Brauer type)
is characterized by the progressive devel-
opment of discrete areas of hyperkerato-
sis on the palms and soles, followed by
more extensive diffuse hyperkeratosis on
the pressure-bearing areas of plantar skin.
Linkage analyses of families affected
by PPKP1 have previously identified aAccepted article preview online 6 June 2013; published online 11 July 2013
Abbreviations: AAGAB, gene encoding alpha- and gamma-adaptin-binding protein p34; bp, base pair;
OMIM, Online Mendelian Inheritance in Man; PPK(P), (punctate) palmoplantar keratoderma; RTK,
receptor tyrosine kinase
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locus within 15q22–q24 (Martinez-Mir
et al., 2003; Gao et al., 2005), but
two Chinese pedigrees with a PPKP1
phenotype demonstrated linkage on
chromosome 8q24.13–q24.21 (Zhang
et al., 2004). Recently, nonsense muta-
tions in AAGAB, the gene encoding
alpha- and gamma-adaptin-binding
protein p34, were reported in three
PPKP1 families (Giehl et al., 2012).
Simultaneously, we applied whole-
exome sequencing and reported heter-
ozygous loss-of-function mutations in
AAGAB in 18 PPKP1 kindreds (Pohler
et al., 2012). AAGAB is located on
chromosome 15q22, within one of
the previously reported linkage regions
(Martinez-Mir et al., 2003; Pohler et al.,
2012). We now report the AAGAB
genotype in a further 12 PPKP1
patients from 6 independent kindreds
of Scottish, English, and Mexican
ancestry. This study was carried out in
accordance with the Declaration of
Helsinki Principles, and all subjects
gave written informed consent.
KINDRED 1
A 56-year-old Scottish woman reported a
15-year history of the progressive devel-
opment of tender callosities on her soles
and palms. Examination revealed multiple
hyperkeratotic foci on the palmar skin of
hands and fingers (Figure 1a) and diffuse
hyperkeratosis on weight-bearing areas of
plantar skin (Figure 1b). The proband’s
parents were unaffected, but one of her
three offspring demonstrated a PPKP1
phenotype. Sequencing of AAGAB using
reported methodology (Pohler et al., 2012)
identified a heterozygous 1-bp deletion,
mutation c.344del resulting in a premature
termination codon (p.Asp115Valfs*7;
Supplementary Figure S1 online). This
mutation has previously been observed
in two apparently unrelated Scottish
families (Pohler et al., 2012).
KINDRED 2
A 74-year-old Scottish woman pre-
sented with a 25-year history of progres-
sive hyperkeratosis of her plantar skin
(Figure 1d), with lesser involvement of
the palmar skin (Figure 1c). The pro-
band’s parents were unaffected, but
one of her three adult children had
keratoderma. DNA sequencing identified
a previously unreported heterozygous
nonsense mutation, c.390G4A, pre-
dicting the protein change p.Trp130*0,
within AAGAB (Supplementary Figures
S1 and S2b online). This mutation
was not detected in B11,000 European
and African American individuals’ exome
sequencing data (NHLBI Exome Seq-
uencing Project http://evs.gs.washington.
edu/EVS/ accessed 27 March 2013), nor
is it reported in the 1000 Genomes
Catalogue of Human Genetic Variation
(http://www.1000genomes.org/ensembl-
browser accessed 27 March 2013).
KINDRED 3
A 79-year-old Scottish man presented
with a 30-year history of hyperkeratosis
of the soles and palms (Supplementary
Figure S3a and b online). His medical
history included a cutaneous squamous
cell carcinoma on the hand and a basal
cell carcinoma on the nose, but these
were not at sites affected by kerato-
derma. The patient’s parents, eight sib-
lings, and two children were unaffected.
DNA sequencing revealed a heterozy-
gous c.870þ 1G4A splice-site muta-
tion within AAGAB (Supplementary
Figure S1 online), previously reported
in an unrelated Scottish family (Pohler
et al., 2012). The protein conse-
quences of this mutation are unknown






Figure 1. Clinical images of punctate palmoplantar keratoderma cases. (a) Proband from kindred
1 illustrating focal punctate callosity on palmar skin and diffuse hyperkeratosis on plantar skin (b). Palm (c)
and sole (d) of a 74-year-old woman from kindred 2 showing punctate lesions coalescing to form focal
areas of marked hyperkeratosis. Affected individuals from kindred 5 showing typical focal calluses on
palmar skin (e) and coalescence of the lesions on plantar pressure points (f). The proband from kindred 6 is
shown in g and h, demonstrating subtle discrete hyperkeratotic papules on the palmar skin with more
marked hyperkeratotic foci, which coalesce in weight-bearing areas on the plantar skin. Arrows indicate
punctate hyperkeratotic lesions. Clinical images from the cases in kindreds 3 and 4 are shown in
Supplementary Figures 3a, b, and 4a, b online.
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KINDRED 4
A 55-year-old female patient of English
ancestry presented at the age of 30 years
with typical features of PPKP1. She had
multiple keratotic papules on palmar
and plantar surfaces, which had gradu-
ally increased in number, becoming
confluent and tender (Supplementary
Figure S4a and b online). The patient
has one affected and four unaffected
siblings; her two daughters are similarly
affected and her one grandson shows
early signs of punctate keratoderma.
DNA sequencing revealed a heterozy-
gous frameshift mutation c.472del,
leading to a premature termination
codon (p.Gly158Glufs*0; Supplemen-
tary Figure S1 online), previously
reported in five apparently unrelated
Scottish families (Pohler et al., 2012).
KINDRED 5
Thirty-one members of this Mexican
family over four generations demon-
strate a PPK1P phenotype with an auto-
somal dominant pattern of inheritance.
The affected living relatives showed
multiple hyperkeratotic papules on the
palms and soles with no associated nail
disease (representative clinical images
are shown in Figure 1e and f). Linkage
analysis in this family has identified the
AAGAB locus at chromosome 15q22
(Martinez-Mir et al., 2003). AAGAB
sequencing of DNA from five affected
family members has now identified
a previously unreported heterozygous
1-bp deletion in exon 3, c.275del
predicting the protein change
p.Leu92Leufs*18, in each affected
individual (Supplementary Figures S1
and S2d online). This mutation was
not detected in B11,000 European
and African American individuals’
exome sequencing data (NHLBI
Exome Sequencing Project http://evs.
gs.washington.edu/EVS/ accessed 27
March 2013), nor is it reported in the
1000 Genomes Catalogue of Human
Genetic Variation (http://www.
1000genomes.org/ensembl-browser
accessed 27 March 2013).
KINDRED 6
A 42-year-old Scottish woman pre-
sented with punctate callosities affecting
her palms and soles, which were present
since early adulthood (Figure 1g and h).
The proband’s mother was affected to a
milder degree, and her 15-year-old son
showed early signs of punctate kerato-
derma on the plantar surfaces. Sequen-
cing of all exons of AAGAB in these
three cases failed to identify any muta-
tions. However, microsatellite linkage
analysis in the pedigree was consistent
with involvement of the AAGAB locus
(Figure 2). Hemizygous inheritance of a
microsatellite marker within intron 1 of
AAGAB indicated a genomic deletion.
A reduction in the gene dosage for
AAGAB exon 1 in the proband
compared with her unaffected father
was confirmed using semiquantitative
fluorescent PCR (Supplementary
Figure S5a and b online), whereas
exons 2 and 3 were amplified in equal
quantities in the proband and control
(Supplementary Figure S5c and d
online). The precise size of this genomic
deletion involving exon 1/intron 1 of
AAGAB has not been defined, but it is
consistent with the resultant haploinsuf-
ficiency of AAGAB.
It has previously been shown that
knockdown of p34 in HaCaT cells
in vitro leads to increased stabilization
of the EGFR protein, a receptor tyrosine
kinase (Pohler et al., 2012). In addition
to EGFR, keratinocytes express several
other receptor tyrosine kinases (RTKs).
To further investigate the functional
effects of AAGAB mutations, we tested
the effect of gene knockdown on the
transmembrane protein Axl, an RTK that
is highly expressed in skin and is
involved in signaling pathways to
cellular proliferation (Postel-Vinay and
Ashworth, 2012). We investigated the
effect of p34 knockdown on Axl in
HaCaT keratinocytes and found a
significant increase in the amount of
Axl protein in cells treated with
AAGAB-specific small interfering RNA
(Supplementary Figure S6 online;
methods are fully described in online
Supplementary Tables S1 and S2
online).
These six kindreds demonstrate repli-
cation of a newly reported genetic cause
for punctate PPK1, further confirming
AAGAB as a causative gene. AAGAB
mutations result in hereditary deficiency
of p34, leading to hyperproliferative
hyperkeratosis through increased growth
factor signaling, which is thought to
result from impairment in the endocy-
tosis and recycling of EGFR proteins
(Pohler et al., 2012).
A total of 13 predicted loss-of-func-
tion mutations have now been reported;
these are listed in Supplementary Table
S3 online. We have identified recurrent
mutations resulting in frameshift and
deleterious splice site changes, as well
as previously unreported variants. There
is no apparent genotype–phenotype
correlation within this small group of
patients, but our clinical observation is
that environmental factors and personal
skin care regimes affect the degree
of plantar hyperkeratosis. The PPKP1
families reported here demonstrate
some diversity in the clinical appear-
ance of plantar hyperkeratosis, whereas
the punctate palmar keratoses have a
more similar appearance in each
kindred (Figure 1).
An association with the development
of malignancy in PPKP1 patients has
AAGAB_intron 1
AAGAB_intron 5 (370, 373)
AAGAB_intron 1  (301,  --- )
AAGAB_intron 5 (370, 405)(373, 373)




Figure 2. Family tree and microsatellite markers showing linkage patterns in kindred 6. Two regions
of microsatellite repeats were screened: one marker within intron 5 and a second marker within intron 1 of
AAGAB. Numbers indicate the length (in base pairs) of PCR products for each marker from each allele. The
microsatellite marker of intron 1 is absent from one allele of AAGAB in PPKP1-affected individuals,
indicating a genomic deletion resulting in hemizygosity.
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been reported, including breast and
colonic adenocarcinoma (Bennion and
Patterson, 1984; Stevens et al., 1996).
It is not clear whether there is truly
an over-representation of malignancy in
PPKP1 cases, and malignant neoplasms
were not prevalent in the six kindreds
reported here.
Hyperkeratosis of the plantar skin
localized to the weight-bearing areas
may be explained by mechanical
trauma, but the extremely focal distribu-
tion of hyperkeratosis on the palmar
skin in the disorder is striking. The
mechanism(s) responsible for producing
this very focal disease on the back-
ground of a mutation expressed through-
out the palmar skin are likely to be of
clinical relevance, but they remain to be
defined. It is possible that a second
mutation has occurred within each
focal area of hyperkeratosis. This was
not identified by microdissection and
sequence analysis (Pohler et al., 2012),
but further investigation is warranted.
A clearer understanding of the genetic
and/or environmental mechanisms by
which focal keratoses arise may give
further insight into the role of p34 in
controlling cell division. Because of
the role of EGFR and Axl in various
malignancies, Axl-specific inhibitors are
under development (Postel-Vinay and
Ashworth, 2012) and are potentially of
relevance to this rare but distressing
keratoderma.
The p34 protein encoded by AAGAB
has been functionally implicated in the
biology of intracellular transport of
membrane-bound, clathrin-coated vesi-
cles. We hypothesized that a possible
link between an inherited defect in
vesicle transport and epidermal hyper-
proliferation might involve RTKs, which
are turned over by endocytosis via
clathrin- and AP2-dependent processes
(Ceresa, 2006; Rappoport and Simon,
2009). The upregulation of Axl protein
expression after small interfering
RNA knockdown of AAGAB demon-
strates the involvement of p34 in
RTK turnover in addition to EGFR. The
identification of molecular mechanisms
in palmoplantar keratoderma serves to
improve our understanding of the patho-
genesis of cutaneous hyperkeratosis.
It may also offer insight into the
control of keratinization in physiologi-
cal conditions, as well as more
prevalent inflammatory skin diseases
characterized by hyperproliferation and
hyperkeratosis.
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